HemaSphere, 2023-08, Vol.7 (S3), p.e1220745-n/a
- Wong, Sandy W.
- Bar, Noffar
- Victoria Mateos, María
- Ribas, Paz
- Hansson, Markus
- Paris, Laura
- Hofmeister, Craig
- Rodriguez‐Otero, Paula
- Aranzazu Bermúdez, Maria
- Santoro, Armando
- Yee, Andrew J.
- Creignou, Maria
- Encinas, Cristina
- Cerchione, Claudio
- Rubia, Javier
- Oriol, Albert
- Ferstl, Barbara
- Besemer, Britta
- Chen, Jinjie
- Chung, Alexander
- Boss, Isaac W.
- Gaudy, Allison
- LI, Shaoyi
- Hsu, Kevin
- Godwin, Colin
- Burgess, Michael R.
- San‐Miguel, Jesús
- Jose Costa, Luciano
2023
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Wong, Sandy W.
- Bar, Noffar
- Victoria Mateos, María
- Ribas, Paz
- Hansson, Markus
- Paris, Laura
- Hofmeister, Craig
- Rodriguez‐Otero, Paula
- Aranzazu Bermúdez, Maria
- Santoro, Armando
- Yee, Andrew J.
- Creignou, Maria
- Encinas, Cristina
- Cerchione, Claudio
- Rubia, Javier
- Oriol, Albert
- Ferstl, Barbara
- Besemer, Britta
- Chen, Jinjie
- Chung, Alexander
- Boss, Isaac W.
- Gaudy, Allison
- LI, Shaoyi
- Hsu, Kevin
- Godwin, Colin
- Burgess, Michael R.
- San‐Miguel, Jesús
- Jose Costa, Luciano
- Titel
- P883: ALNUCTAMAB (ALNUC; BMS‐986349; CC‐93269), A BCMA × CD3 T‐CELL ENGAGER, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): LATEST RESULTS FROM A PHASE 1 FIRST‐IN‐HUMAN CLINICAL STUDY
- Ist Teil von
- HemaSphere, 2023-08, Vol.7 (S3), p.e1220745-n/a
- Ort / Verlag
- Philadelphia, PA: Lippincott Williams & Wilkins
- Erscheinungsjahr
- 2023
- Quelle
- Alma/SFX Local Collection
- Sprache
- Englisch
- Identifikatoren
- ISSN: 2572-9241eISSN: 2572-9241DOI: 10.1097/01.HS9.0000970436.12207.45Titel-ID: cdi_doaj_primary_oai_doaj_org_article_2230834f84a148e3a0a1059145ec090f
- Format
- –